Panelists discuss emerging regimens and agents being explored for the future treatment of advanced HER2+ breast cancer, highlighting the potential innovations that may improve patient outcomes.
Dr Iyengar: At a high level, what new regimens or agents are being explored that you are hopeful for in the future treatment of advanced HER2+ breast cancer?